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Background: Somatic mosaicism of copy number variants (CNVs) in human body organs and de novo CNV event
in monozygotic twins suggest that de novo CNVs can occur during mitotic recombination. These de novo CNV
events are important for understanding genetic background of evolution and diverse phenotypes. In this study, we
explored de novo CNV event in cloned dogs with identical genetic background.
Results: We analyzed CNVs in seven cloned dogs using the nuclear donor genome as reference by array-CGH, and
identified five de novo CNVs in two of the seven clones. Genomic qPCR, dye-swap array-CGH analysis and B-allele
profile analysis were used for their validation. Two larger de novo CNVs (5.2 Mb and 338 Kb) on chromosomes X
and 19 in clone-3 were consistently validated by all three experiments. The other three smaller CNVs (sized from
36.1 to76.4 Kb) on chromosomes 2, 15 and 32 in clone-3 and clone-6 were verified by at least one of the three
validations. In addition to the de novo CNVs, we identified a 37 Mb-sized copy neutral de novo loss of heterozygosity
event on chromosome 2 in clone-6.
Conclusions: To our knowledge, this is the first report of de novo CNVs in the cloned dogs which were generated by
somatic cell nuclear transfer technology. To study de novo genetic events in cloned animals can help understand
formation mechanisms of genetic variants and their biological implications.
Keywords: Cloned dog, De novo copy number variation, Mosaicism, Loss of heterozygosity, Somatic cell nuclear transferBackground
Together with single nucleotide polymorphisms (SNPs),
DNA structural variations generally termed copy num-
ber variations (CNVs) are the major part of genomic var-
iations in diverse animals including dogs [1,2]. CNVs are
thought to contribute to phenotypic diversities including
disease susceptibility and provide the important sub-
strate for evolution [3,4]. Although it has been widely
believed that all the cells in one individual are genetically
identical, this dogma is changing due to our understand-
ing of genomic variants. Indeed, recent studies have
demonstrated the somatic mosaicism of CNVs in body
organs [5,6], which suggests that de novo CNV events* Correspondence: bclee@snu.ac.kr; yejun@catholic.ac.kr
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reproduction in any medium, provided the ormay commonly occur during mitotic recombination [7].
This possibility was clearly demonstrated by Bruder et
al’s report identifying de novo somatic CNV events in
monozygotic (MZ) twins [8]. They showed that the de
novo post-twinning CNV frequency could be as high as
5% on a per-individual basis or 10% per twinning event.
Also, Breckpot et al. reported CNVs in 1 out of 6 pheno-
typically discordant MZ twins [9]. These results sug-
gest that CNV analysis in phenotypically discordant MZ
twins can be useful to identify genetic loci associated
with various traits. However, the de novo rate of somatic
CNV mosaicism events is still largely unknown. For the
case of cloned dogs, there has been no report about the
de novo somatic CNV mosaicism event itself.
Dogs (Canis familiaris) have been used as working an-
imals due to their superior sniffing ability to any other
species or machine. For example, a cancer-sniffing dog
can detect the existence of colorectal cancer from stool
samples with 97% sensitivity and 99% specificity [10].
However, up to 70% of dogs that were bred fromd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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they lack trainability [11]. To reduce the tremendous
cost, effort, and time to train one working dog, dog-
cloning technology has been applied for the propagation
of elite working dogs [12].
In this study, we aimed to identify de novo somatic
CNV events which may exist in cloned dogs with identi-
cal genetic backgrounds like in human MZ twins using
microarray-based comparative genomic hybridization
(array-CGH). Array-CGH is one of the most popular
and useful tools to analyze genome-wide CNV profiles
and a number of studies have identified canine CNVs
using this technique [13-17]. We validated the CNVs by
diverse analyses such as genomic qPCR, dye-swap array-
CGH, and B-allele profile analysis. We examined the
genome-wide de novo somatic CNV events for the seven
cloned dogs generated in our previous study [12] and
identified five de novo CNV events.
Results
Validation of custom canine-array
We designed a custom array containing an average
probe spacing of 3.3 Kb across the whole canine genome
for CNV screening. Before analyzing potential CNVs
among the seven cloned dogs, we first validated
whether this custom array platform could reliably de-
tect CNVs between different canine breeds. For this, we
screened CNVs between the nuclear donor, a Labrador
retriever genome (male), and a Boxer genome as refer-
ence (female) using array-CGH, and verify the CNVs by
genomic qPCR. Under our CNV detection criteria, we
identified 72 CNVs between the Labrador retriever and
Boxer across diverse chromosomes spanning 0.35%
(8.6 Mb) of the canine genome. The average CNV size
was 119 Kb (ranging from 11.1 to 450.6 Kb). Figure 1A
illustrates the whole-genome plot of copy number gain-
and loss-CNVs (CNV-G and CNV-L, respectively) identi-
fied with our array. Details of the 72 CNVs are available in
Additional file 1: Table S1. When we compared the 72
CNVs with previously identified dog CNV regions [14-17],
90.3% (65 of 72 CNVs) identified in this study overlapped
with the previously reported canine CNVs, while seven
(9.7%) were novel. Statistical significance of enriched CNV
overlap with known dog CNV data was evaluated by per-
mutation test as described previously [18]. The overlap
with known dog CNV data was significantly not a random
event (P < 0.001). To validate our array platform and our
CNV defining criteria through genomic qPCR, we ran-
domly selected nine CNV loci (2 CNV-Ls, and 7 CNV-
Gs) out of the 72 CNVs and designed eleven primer sets
targeting the nine loci. All the eleven qPCRs in the nine
CNV loci showed consistent copy number changes that
matched the array results (Figures 1B, 1C). We also vali-
dated the seven novel CNVs. The average size of the novelCNVs was 103.5 Kb (ranging from 26.8 to 235.7 Kb) and
all of them were consistently validated by genomic qPCR
(Additional file 1: Figure S1). Since one of the 7 novel
CNVs (on chromosome 4) was included in the nine valid-
ation targets, a total of 15 CNVs were qPCR validated in
this study. All these data supported the reliability of our
customized array platform and the subsequent analyses
for identifying canine CNVs, therefore we applied this sys-
tem to analyze cloned dog genomes.
Association with segmental duplications and repetitive
sequences
To understand the mechanism of CNV formation, we
assessed the association of CNVs with segmental dupli-
cations (SDs) and repetitive sequences. When we com-
pared the 72 CNVs with the CNV data from Nicholas et
al’s report, which systematically analyzed SDs and associ-
ated CNVs in canis familiaris [15], 48 (67%) overlapped
with the SDs. Total length of the overlapped CNVs was
about 6 Mb (~70% of the total length of the 72 CNVs).
This result was coherent with Nicholas et al’s previous
report demonstrating that 70% of CNVs were associated
with SDs [16]. Considering that SDs are often substrates
of CNV formation via non allelelic homologous recom-
bination (NAHR) [3], ours and previous results suggest
that SD-associated NAHR might be the major mechan-
ism of canine CNV generation. When we observed the
genomic fraction (fraction of retroelements per kb) of long
interspersed elements (LINE), short interspersed elements
(SINE) and long terminal repeats (LTR) within (intraCNV)
or in the vicinity of the CNVs (up to 10 Mb), LINE ele-
ments were relatively enriched the flanking regions (up to
10 kb away from CNVs), while relatively depleted LINEs/
SINEs in intraCNV (Additional file 1: Figure S2). This re-
sult is coherent with the previous reports suggesting that
repeated sequences may play a role in the formation of
structural variation and genomic diversity [19,20].
De novo CNVs identified in the cloned dogs
To verify the genetic homogeneity between the donor
dog and clones, we first performed the microsatellite-
based evaluation of the individual identity. Being consist-
ent with our previous report [12], all seven cloned dogs
showed identical microsatellite patterns with the donor
at all nine microsatellite markers examined (Additional
file 1: Table S2). We calculated the probability that the
clone should have the same genotype as the donor under
two different assumptions: assuming Hardy–Weinberg
equilibrium, and assuming that both individuals are sib-
lings as described previously [21,22]. The probabilities of
exact allele matching at the nine microsatellite markers
in a population of Labrador retriever (Hardy-Weinberg
P = 0.00048 and Full siblings P = 0.01763) suggest that
allele matching at all nine microsatellite loci is not a
Figure 1 Whole-genome plot of CNVs and qPCR validation. (A) Whole-genome plot of CNVs identified between Labrador retriever and Boxer
genomes. Nine CNV regions (7 CNV-Gs, red arrow; 2 CNV-Ls, green arrow) were randomly selected for qPCR validation. The X-axis represents indi-
vidual chromosomes and the Y-axis represents signal intensity ratios (Labrador retriever/Boxer) on a log2 scale. (B) Log2ratio plot around the nine
selected CNV regions. Black bars represent primer position for qPCR validation. The X-axis represents genomic position (Mb) and the Y-axis repre-
sents signal intensity ratios (Labrador retriever/Boxer) on log2 scale. (C) Three primer sets located in the CNV-L regions detected copy loss, and
the other eight primer sets located in the CNV-G regions detected copy gain. The red and green line represent detection criterion for copy gain
and copy loss, respectively. The Y-axis represents fold change based on the Boxer as the calibrator.
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CGH-based CNV screening to identify de novo CNVs in
cloned dogs. For this, genomic DNA from the nuclear
donor dog was used as the universal reference for each
array-CGH. Therefore, all the CNVs identified can be
interpreted as de novo ones. Under the same CNVdetection criteria as in the validation experiment, we
identified five de novo CNVs in two of the seven cloned
dogs ranging from 36 Kb to 5.2 Mb (Table 1). Among
the five de novo CNVs, a 36 Kb-sized CNV on chromo-
some 2 (cloned dog-6) did not overlap with the previ-
ously reported canine CNVs, while the other four
Table 1 De novo CNVs in cloned dogs
Clone Chr Start (bp) End (bp) Length (bp) Event Genes* Validated by† Reported CNV§
Clone-3 15 32,983,895 33,026,044 42,150 CN Gain - Q, S Yes
Clone-3 19 23,000,913 23,338,557 337,644 CN Gain - Q, S, B Yes
Clone-3 32 41,654,990 41,731,424 76,435 CN Gain - Q, S Yes
Clone-3 X 1,401,988 6,598,355 5,196,367 CN Gain ARSE, ARSH, OBP, GYG2, ARSD, ARSF, MXRA5,
PRKX, PRKY, NLGN4T, NLGN4X, HDHD1, STS,
PNPLA4, AKL1, TAF9, APOO, SHROOM2
Q, S, B Yes
Clone-6 2 71,652,481 71,688,546 36,066 CN Loss ZBTB8A, PCNAP1 Q No
*Bold text indicates reference genes in canine and regular text indicates reference genes in human.
†Q, genomic qPCR; S, dye-swap array-CGH analysis; B, B-allele profile analysis.
§Overlapped with the previously reported CNVs [14-17].
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The overlap with known dog CNV data was significantly
not a random event (P < 0.001). Figure 2A is the genome-
wide signal intensity plot (log2 scale) in cloned dog-3
(clone-3) as an example. To validate the de novo CNVs,
we first carried out dye-swap array-CGH analysis for the
clone-3 genome, but not for the clone-6 genome due to
the lack of genomic DNA. Dye swap is a repeating
hybridization on two-dye microarrays with the sameFigure 2 Dye-swap analysis for the clone-3 genome. (A) Genome-wide
the clone-3 genome (red arrow). The X-axis represents individual chromosom
log2 scale. (B) Log2ratio plots around the four CNV regions in clone-3. All CN
(green line) in the dye-swap hybridization. The X-axis represents genomic possamples but with swapped fluorescent labels. If there is
true copy number change, the test/reference intensity ra-
tio value must be inverted by the switching of the dyes.
The concordant copy number changes detected in dye-
swap analysis were considered to be true changes. As ex-
pected, all four CNVs identified in clone-3 consistently
showed flipped signal intensity plots in the dye-swap
hybridization (Figure 2B), supporting the accuracy of the
CNVs identified by array-CGH.signal intensity plot from clone-3. Four CNV regions were identified in
es and the Y-axis represents signal intensity ratio (clone-3/donor) on a
V-Gs identified in clone-3 (red line) show flipped signal intensity plots
ition (Mb), and the Y-axis represents signal intensity ratio on a log2 scale.
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In addition to the dye-swap analysis, we also performed
whole-genome SNP genotyping for the genomes of the
donor and cloned dogs using an Illumina CanineHD
170 K SNP array to obtain a more reliable interpretation
of the de novo CNVs. A 5.2 Mb-sized region of copy
number gain on chromosome X identified by array-CGH
in clone-3 clearly showed two heterozygous clusters of
SNPs in the B-allele plot, while no copy number gains or
heterozygous clusters of SNPs were detected in the
donor genome (Figure 3A). The 338 Kb-sized copy
number gain on chromosome 19 of clone-3 also
showed two heterozygous clusters of SNPs in the B-
allele plot that were not detected in the donor genome
(Figure 3B). The other three CNVs on chromosome 2,
15 and 32 were too small to be interpreted by B-allele
pattern (Additional file 1: Figure S3).
In addition to the de novo CNVs, we identified a copy
neutral de novo loss of heterozygosity (LOH) event on
chromosome 2 by the B-allele pattern analysis. ThisFigure 3 Examples of allelic imbalance in clone-3. (A) Upper panel, Log
region on chromosome X was identified in clone-3 (black arrow). The X-ax
tensity ratio on a log2 scale. Lower panel, B-allele plot of the proximal part
was detected in chromosome X (black arrow), and this allelic imbalance ha
Log2ratio plot on chromosome 19 in the clone-3. A 338-Kb copy number g
Lower panel, B-allele plot of the dashed box on chromosome 19. A hetero
allelic imbalance has same position as the copy gain region.37 Mb-sized LOH was identified in the distal end of
chromosome 2 in clone-6, but not in the nuclear donor
nor in the other cloned dogs (Figure 4).
Genomic qPCR validation of the de novo CNVs
To validate the existence and boundaries of the CNVs, we
performed genomic qPCR for multiple points within and
outside the expected CNV breakpoints. For this, we de-
signed two to seven target specific primer pairs for each
CNV (Additional file 1: Table S3). Through multiple-point
genomic qPCR, four of the five CNVs were consistently
validated, while the other one relatively smaller sized
CNV was not validated (Figure 5). In the 5.2 Mb-sized
region of copy number gain on chromosome X and the
338 Kb-sized gain on chromosome 19 in clone-3, all
the qPCRs within the CNV regions consistently showed
copy number gains and the qPCRs outside CNV region
showed diploid copy numbers, which confirmed the ac-
curacy of our array-CGH analysis in defining boundar-
ies (Figures 5A, 5B). Likewise, all the other cloned dogs2ratio plot on chromosome X in clone 3. A 5.2-Mb copy number gain
is represents genomic position (Mb) and the Y-axis represents signal in-
of chromosome X (dashed box of upper panel). A heterozygous cluster
s the same genomic position as the copy gain region. (B) Upper panel,
ain region on chromosome 19 was identified in clone-3 (black arrow).
zygous cluster was detected on chromosome 19 (black arrow), and this
Figure 4 Example of the LOH event in clone-6. A 37-Mb de novo LOH event was identified on the distal end of chromosome 2 in clone-6 that
was not detected in the donor or other clones. The X-axis represents genomic position (Mb), and the Y-axis represents B-allele intensity.
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Of the relatively smaller-sized CNVs, a 36 Kb copy
number loss on chromosome 2 in clone-6 and 42 Kb
gain on chromosome 15 in clone-3 were successfully
validated and their boundaries were estimated by qPCR
(Figure 5C, 5D). However, the 76 Kb-sized CNV-G on
chromosome 32 in clone-3 was not validated by gen-
omic qPCR (Figure 5E).
Discussion
In this study, we aimed to identify de novo post-cloning
CNV events which may exist in cloned dogs like in hu-
man MZ twins. For this purpose, we designed a 720 K
custom array by merging the NimbleGen 385 K dog
array as a backbone and 335 K probes for known canine
CNV regions [14]. Using this platform, we identified five
de novo CNVs in two of the seven cloned dogs from the
same nuclear donor. Our findings support the occur-
rence of de novo post-cloning CNV events in mammalsincluding dogs. Although de novo CNV events in
phenotypically concordant MZ twins have been reported
in humans [8], to the best of our knowledge, this is the
first report of de novo CNVs in cloned animals including
dogs generated by SCNT technology.
As mentioned above, the de novo CNVs were unevenly
identified across the dog clones (2/7 clones); four CNVs
were identified in one clone (clone-3) and one was in
another clone (clone-6). Our result is similar with the
previous reports observing the CNVs in human MZ
twins. Breckpot et al. identified CNVs in 1 out of 6
phenotypically discordant MZ twins [9]. In Ehli et al’s
report with 50 concordant and discordant MZ twins, 18
de novo post-twining CNVs were detected in 14 out of
45 twin pairs [23]. However, we cannot rule out the pos-
sibility of existence of more de novo CNVs because the
array platform and defining algorithm we used in this
study cannot be perfect. Also, it is possible that some
genetic events may have happened in the clone-3
Figure 5 Multiple-point genomic qPCR validation. Left, Log2ratio plot on chromosome X (A), chromosome 19 (B), chromosome 15 (D),
chromosome 32 (E) in clone 3 and chromosome 2 (C) in clone-6. Red and green bars represent primer position within the CNV-Gs and CNV-Ls,
respectively. Black bars represent primer position outside the expected CNV breakpoint. The X-axis represents genomic position (Mb) and the
Y-axis represents signal intensity ratio on a log2 scale. Right, multiple-point genomic qPCR validation. The Y-axis represents fold-change based on
the nuclear donor as calibrator.
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procedure. Further CNV studies with a larger number
of cloned dogs will be required to understand this
phenomenon.
When we screened CNVs between the donor Labrador
retriever and a Boxer to validate the performance of ourcustom array, the number of CNVs was largely similar
to the report by Nicholas et al. that compared CNVs
using a 2.1 M array between nine breeds of modern do-
mestic dogs including Labrador retriever [16]. Most of
the CNVs (90.3%) identified in our validation experi-
ment overlapped with the previously reported CNVs
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event (P < 0.001). All the nine randomly selected CNV
loci and seven novel CNVs identified by array-CGH
showed consistent copy number changes that were vali-
dated by qPCR. These results suggest the reliability of our
custom array and CNV defining procedure. Although ex-
ploring the novel canine CNVs is not our aim in this
study, this result suggests that a substantial number of ca-
nine CNVs that have yet to be identified.
To validate the five de novo CNVs in the cloned dogs,
we performed three different verification experiments;
genomic qPCR, dye-swap array-CGH analysis and B-
allele profile analysis. Two larger de novo CNVs (5.2 Mb
and 338 Kb) on chromosomes X and 19 in clone-3 were
consistently validated by all three experiments. The
other three CNVs on chromosomes 2, 15, and 32 (36.1 -
76.4 Kb) seem to be too small to be interpreted by B-allele
pattern (Additional file 1: Figure S3). According to the
technical note about CNV analysis algorithm for Illumina
HumanHap240S array, which has a higher SNP density
than the array used in this study (170 K), the minimum
recommended window size for LOH score algorithm is
360 Kb [24]. Of the three smaller-sized CNVs, two (a CNV
on chromosome 2 in clone-6 and another one on chromo-
some 15 in clone-3) were verified by qPCR, but the CNV
on the distal end of chromosome 32 was not verified.
However, the CNV region on chromosome 32 was vali-
dated in dye-swap analysis, which suggests that the 76 Kb-
sized CNV region on chromosome 32 might be real.
There are several genes in the 5.2 Mb-sized copy
number gain CNV locus including the neuroligin 4 X-
linked (NLGN4X), steroid sulfatase isozyme S (STS),
and odorant-binding protein (OBP) genes. In human,
genetic variants of the NLGN4X gene have been re-
ported to be associated with autism spectrum disorder
in Japanese and Han Chinese populations [25-27]. A
CNV of the STS gene (duplication) has also been re-
ported to be associated with intellectual disability in
human [28]. OBP is small soluble carrier protein that
belongs to the family of lipocalins and that may be in-
volved in the perception of pheromones [29]. However,
we did not observe any differences regarding the phe-
notypes related to these genes in the cloned dogs har-
boring the de novo CNVs in this study.
In addition to the de novo CNVs, we also detected a
copy neutral de novo LOH event on chromosome 2.
This 37 Mb-sized LOH event occurred in a cloned dog
but was not present in the nuclear donor dog, indicating
that the uniparental disomy (UPD) arose from a mitotic
event in the cloned dog. It is well known that UPD is a
genetic event associated with human diseases and mosai-
cism of aneuploidy can be associated with UPD [30].
Our results suggest that SCNT could result in UPD-
related phenotypic differences among clones.There are several limitations in this study. First, since
the sample size of this study is very small, the scope of
our analysis could not go beyond describing de novo
CNVs. Second, even though we identified de novo CNVs
in cloned dogs, we could not analyze any association be-
tween the CNVs and phenotypic characteristics, because
there have been no phenotypic differences among them
so far. To overcome both limitations and draw biologic-
ally meaningful conclusions, we need to clone more dogs
and to carefully observe the phenotypes of them, and
apply more informative technologies such as whole gen-
ome sequencing.
Conclusions
In conclusion, we identified de novo CNV and LOH
events in cloned dogs generated from one nuclear
donor. To the best of our knowledge, this is the first re-
port of de novo CNVs in cloned animals including dogs
generated by SCNT technology. Since cloned animals
share almost identical genetic background like MZ
twins, to study their de novo genetic events can help
understand formation mechanisms of genetic variants
and their biological implications. Also, our results can
be a useful tool to study the genetic basis of diverse dis-
ease/phenotype traits in dogs.
Methods
Source of dog DNA samples
Seven cloned Labrador retriever dogs named clone-1
to −7 were generated by somatic cell nuclear transfer
(SCNT) using fibroblasts derived from a seven-year-
old Labrador retriever, and the genetic homogeneity was
validated by microsatellite analysis using nine markers
(PEZ01, PEZ02, PEZ03, PEZ06, PEZ13, PEZ17, FH2079,
FH2054, FH2010) in the previous study [12]. In order to
extract genomic DNA samples, blood was collected from
the seven cloned dogs at three years of age and from the
donor dog at ten years of age. Approximately 5 ml of
blood was collected into anticoagulant tubes containing
EDTA. Genomic DNA was extracted from whole-blood
using a DNeasy Blood & Tissue Kit (Qiagen, Hilden,
Germany) and quantified by NanoDrop spectrophotom-
eter. This study was performed with the approval of ani-
mal ethics committee of Seoul National University.
Whole-genome array-CGH experiment
We used a NimbleGen custom 720K canine whole-
genome array platform (Roche NimbleGen, Penzberg,
Germany), designed from the UCSC dog genome build
of May 2005 (Broad/canFam2). This array is comprised
of 385,000 probes evenly distributed throughout the
unique sequence of the genome as a backbone and an
additional ~330,000 probes which were designed based
on previously reported dog CNV regions [14]. The
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was ~3.3 Kb. The array-CGH experiments were per-
formed according to the manufacturer’s instructions. In
brief, 1 μg genomic DNA from each cloned dog was la-
beled with Cy3-dCTP. The reference DNA was labeled
with Cy5-dCTP. Each dye-labeled DNA was purified and
mixed with hybridization reagents, applied on the array
and incubated for 48 hours at 42°C in a MAUI
hybridization machine (BioMicro, Salt Lake City, UT).
After washing the slides, arrays were scanned using a
GenePix 4000B scanner (Axon Instruments, Sunnyvale,
CA). Image separation, signal intensity extraction, and
normalization were performed using the NimbleScan
software version 2.5 (Roche NimbleGen).
Detection of CNVs
The Rank-Segmentation CNV calling algorithm in
NEXUS software v3.1 (BioDiscovery Inc., El Segundo,
CA) was used to define CNVs of each sample. The pa-
rameters for defining CNVs were as follows: significance
threshold = 1.0E-6; maximum contiguous probe spacing
(Kbp) = 1000 Kb; minimum number of contiguous
probes per CNV segment = 5; threshold of signal inten-
sity ratio > 0.2 on the log2 scale for gains and < −0.2 on
the log2 scale for losses.
Whole-genome SNP genotyping
Genome-wide SNP genotyping was conducted using the
CanineHD SNP array, which contains 173,662 SNP
markers (Illumina, Inc., San Diego, CA) according to
manufacturer’s instructions. The average probe spacing
is 13 Kb. The raw data consisted of the signal intensity
(log R ratio: LRR) and allelic intensity (B allele fre-
quency) that were obtained using GenomeStudio soft-
ware (Illumina, Inc.). Based on the B allele frequency
profile, we defined the CNVs according to the concept of
integrating SNP and CNV genotyping [3]. Samples that
did not have a standard deviation (SD) of LRR < 0.24 were
excluded for quality control. The SNPRank Segmentation
algorithm in NEXUS software was used to define allele
imbalance of each sample.
Genomic quantitative PCR analysis
Array-CGH results were experimentally validated by
genomic qPCR in randomly selected CNV loci for boxer
and all CNV loci for cloned dogs. As a diploid internal
control, a genomic region on chr7:18946362 that showed
no genomic alteration in the array-CGH data was used.
Details including primer information for targets and the
diploid control locus are available in Additional file 1: Table
S3. Genomic qPCR was performed using the ViiA7™ real-
time PCR system (Life Technologies, Carlsbad, CA) as de-
scribe elsewhere [31]. In brief, a 10 μl of reaction mixture
contained 10 ng of genomic DNA, THUNDERBIRD™SYBR qPCR Mix (TOYOBO, Osaka, Japan), 1× ROX, and
6 pmole of each primer. Thermal cycling conditions con-
sisted of one cycle of 1 min at 95°C followed by 40 cycles
of 5 sec at 95°C, 10 sec at 61°C, and 20 sec at 72°C. All
qPCR experiments were triplicate and the copy number of
each target was defined as 2-ΔΔCT, where ΔCt is the differ-
ence in threshold cycles of the sample in question normal-
ized against the reference region and expressed relative to
the value obtained by calibrator DNA (individual/calibrator)
as describe elsewhere [32]. DNA from the nuclear donor
dog was used as calibrator for all qPCR experiment.Probability of identity
Probability of identity (PI) for multilocus microsatellite
data was computed using GENECAP program [33]
under the two different assumptions of Hardy-Weinberg
equilibrium and the sibling PI as described previously
[21,22]. Where, PI indicates the probability of two indi-
viduals within the population sharing the same genotype.
In GENECAP, multilocus PI values were computed by
mutiplying all locus-specific PIs under the assumption
that each locus is independent.Significance of enriched CNV overlap with known dog
CNV data
Statistical significance of enriched CNV overlap with
known dog CNV data was evaluated by permutation
test as described previously [18]. In this test, original
CNV overlap with database was calculated based on >1 bp
overlap measure. In each iteration, CNVs were ran-
domly reshuffled while maintaining their sizes and
numbers within each chromosome. Based on these per-
muted CNVs, we calculated the overlap with the same
database. After repeating this process 1000 times, we
calculated P-value as the fraction of tests where the
number of overlaps was greater than the original unper-
muted CNV overlap.Statistical analyses
Statistical analyses were performed using SPSS version
18.0 (SPSS Inc., Chicago, IL). P values < 0.05 were con-
sidered significant.Availability of supporting data
The array-CGH data (NimbleGen custom 720 K canine
whole-genome array) and the SNP genotyping data
(Illumina CanineHD SNP array) from this study are
submitted to the NCBI Gene Expression omnibus
(http://www.ncbi.nlm.nih.gov/geo) under accession no
GSE49092 and GSE49123, respectively. The following
supporting data are available with the online version of
this paper.
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Additional file 1: Table S1. CNVs between Labrador retriever and Boxer
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information of the primers for genomic qPCR validation. Figure S1. Novel
CNVs identified between a Labrador retriever and a Boxer, and qPCR
validation. Figure S2. Genomic fraction of the repetitive sequence elements.
Figure S3. B allele profiles around the three small-sized de novo CNVs.
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